Yao Shangkun: Foreign Capital Bolsters Revaluation of China's Market, Highlighting Biomedicine and AI as Strategic Pillars
1 week ago / Read about 0 minute
Author:小编   

Yao Shangkun, Chairman of Guoxiong Capital Co., Ltd., emphasized that foreign investment interest in China's cutting-edge technology sector has witnessed a marked resurgence. Over the past few months, his team has actively engaged with numerous high-profile overseas Limited Partners (LP) executives. Notably, some investors who had abstained from visiting China for several years have now resumed in-depth explorations of the Chinese market, particularly focusing on biomedicine and artificial intelligence (AI), among other domains. This influx of foreign capital underscores the reevaluation and acknowledgment by international investors of the enduring value proposition of the Chinese market.